The latest closing stock price for Neumora Therapeutics as of November 04, 2024 is 11.71.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-279 today, roughly 0 times their original investment - a -27.94% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 79.3% above the current share price.
The Neumora Therapeutics 52-week low stock price is 8.33, which is 28.9% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 12.89.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-279 today, roughly 0 times their original investment - a -27.94% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 79.3% above the current share price.
The Neumora Therapeutics 52-week low stock price is 8.33, which is 28.9% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 12.89.